SALVAGE RADIOTHERAPY FOR pT3 PROSTATE CANCER WITH PSA FAILURE AFTER RADICAL PROSTATECTOMY

We assessed the effectiveness of salvage radiotherapy in 13 patients at pathologic stage T3 (pT3) with prostate specific antigen (PSA) failure after radical prostatectomy: 9 patients at pT3a and 4 patients at pT3b. Three-dimensiona l dynamic conformal radiotherapy was used for all patients in this study ， and the median radiation dose was 57.7 Gy (range ， 44-70 Gy) in daily amounts of2 Gy. The median follow-up after salvage radiotherapy was 643 days (range ， 193-1 ，562 days). In 12 ofthe 13 patients ， PSA levels decreased after salvage radiotherapy ， but in 1 patient ， the PSA level increased and hence the treatment was discontinued at 44 Gy. However ， 10 patients exhibited a lasting PSA response. The 3-year biochemical progression-free rate was 74 %， and no serious acute or late toxicity was observed during the follow-up. Salvage radiotherapy is likely to become one of the effective treatments for the patients at pT3 with PSA failure following radical prostatectomy. (Hi 町okika Kiyo 51 : 575-580 ， 2005)